Epidemiology, risk factors, species distribution, and antifungal susceptibility of candidemia among hospitalized patients with COVID-19
Background and Purpose: The pandemic of COVID-19 has caused a worldwide healthcrisis. Candidemia is a potentially lethal condition that has not yet been enough discussed in patients with COVID‐ 19. The current study aimed to investigate the prevalence of candidemia among Iranian COVID‐ 19 patients a...
Main Authors: | Hasti Kamali Sarvestani, Shahram Mahmoudi, Pegah Afarinesh khaki, Saham Ansari, Sara Ghaderkhani, Davoud Roostaei, Roshanak Daie Ghazvini, Seyed Jamal Hashemi, Zahra Rafat, Alireza Abdollahi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2021-12-01
|
Series: | Current Medical Mycology |
Subjects: | |
Online Access: | http://cmm.mazums.ac.ir/article_140980_fc50bc1cc883ca488f82e7f22191e5ef.pdf |
Similar Items
-
PCR-RFLP Is a Useful Tool to Distinguish between C. Dubliniensis and C. Albicans in Cancer Patients in Iran
by: Zohreh Saltanatpouri, et al.
Published: (2010-06-01) -
PCR-RFLP Is a Useful Tool to Distinguish between C. Dubliniensis and C. Albicans in Cancer Patients in Iran
by: Zohreh Saltanatpouri, et al.
Published: (2010-04-01) -
PCR in Comparison with Culture Methods for The Diagnosis of Candida albicans Responsible for Candidemia in Leukemic Patients
by: Saba Sabeeh, et al.
Published: (2019-11-01) -
PCR in Comparison with Culture Methods for The Diagnosis of Candida albicans Responsible for Candidemia in Leukemic Patients
by: Saba Sabeeh, et al.
Published: (2019-11-01) -
Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients<subtitle>Non-albicans candidemia in cancer patients</subtitle>
by: Ping-Feng Wu, et al.
Published: (2017-01-01)